SEBI v. Anvita Trading Company Private Limited (preferential allotment, Secunderabad Healthcare, 2022)

Dismissed

✓ Checked against the primary document on October 9, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, in a single reading of the order; an independent second reading of 60 SEBI records agreed on every field for 56, the four misses being penalty amounts; a later sample of 50 of the SEBI records added on 9 October agreed on every field for 46. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.

Report an error in this record (sebi-58516-market-abuse-2022) by email

In April 2022 a SEBI adjudicating officer disposed of proceedings against Anvita Trading Company without penalty, finding the alleged fraud over a 2010 preferential allotment of Secunderabad Healthcare warrants not established. The officer concluded that the allottee had in fact paid the full subscription money on time.

The record

What was ordered

Civil penalty

—

Disgorgement

—

Prejudgment interest

—

Total relief

—

Alleged gain

—

A dash means the release did not state a figure we could extract, not that the figure is zero. Penalty and disgorgement are stored separately so aggregates across the library do not double-count the same dollars.

What is alleged to have happened

The order of 28 April 2022 concerns Anvita Trading Company Private Limited, one of 27 non-promoter entities that received convertible warrants in a 2010 preferential allotment by Secunderabad Healthcare Limited, a company listed on BSE. Anvita was allotted 36,25,000 warrants, which converted into shares at Rs 18.60 each in March 2011 for a total subscription price of Rs 6,74,25,000.

SEBI alleged that the funds Anvita transferred to the company came to only about Rs 2.48 crore, well short of the required amount, and that the company and the allottee together gave the public a false impression of capital infusion. On that basis SEBI charged breaches of the preferential-issue payment rules in the ICDR Regulations and fraud under section 12A of the SEBI Act and Regulations 3 and 4(1) of the PFUTP Regulations, with adjudication under sections 15HA and 15HB.

Anvita answered that it had paid the full price in stages between August 2010 and February 2011, and relied on a Whole Time Member order of 30 April 2021 that had already exonerated it on the same facts. The adjudicating officer checked the bank statements and agreed that the whole Rs 6,74,25,000 reached the company by 26 February 2011, within the deadline that applied on 2 March 2011.

The officer therefore held the ICDR and fraud allegations unsustainable and disposed of the proceedings. No penalty, direction or restriction was imposed, so there is no monetary sanction to record.

The record does not show whether SEBI appealed, how the other allottees in the same scheme fared in this order, or the effect of the allotment on the share price. The finding is that this allottee paid in full, not that the scheme as a whole was sound.

This library tags the matter as a preferential-allotment fraud matter that was dismissed, with no technique assigned. The tagging is ours, not the regulator's.

For the regulator's own account of the facts, read the primary document linked above. This page deliberately summarises the structured record rather than reproducing the order.

Timeline

1. 2022-04-28 SEBI adjudication order disposing of proceedings (28 April 2022)

Primary documents

Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.

• SEBI order
• Order (PDF)

The linked release is published by the issuing regulator under its own terms. Our summary and narrative above are our own writing.

Record added October 8, 2026. submit a correction.